228 related articles for article (PubMed ID: 29730720)
1. Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.
Ikoma N; Das P; Hofstetter W; Ajani JA; Estrella JS; Chen HC; Wang X; Callender RA; Zhu C; Roland CL; Fournier KF; Cormier JN; Mansfield P; Badgwell BD
Gastric Cancer; 2018 Nov; 21(6):1004-1013. PubMed ID: 29730720
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma.
Zafar SN; Blum M; Chiang YJ; Ajani JA; Estrella JS; Das P; Minsky BD; Hofstetter WL; Mansfield P; Badgwell BD; Ikoma N
Ann Thorac Surg; 2020 Aug; 110(2):398-405. PubMed ID: 32289300
[TBL] [Abstract][Full Text] [Related]
3. Impact of external-beam radiation therapy on outcomes among patients with resected gastric cancer: a multi-institutional analysis.
Ejaz A; Spolverato G; Kim Y; Squires MH; Poultsides G; Fields R; Bloomston M; Weber SM; Votanopoulos K; Worhunsky DJ; Swords D; Jin LX; Schmidt C; Acher AW; Saunders N; Cho CS; Herman JM; Maithel SK; Pawlik TM
Ann Surg Oncol; 2014 Oct; 21(11):3412-21. PubMed ID: 24845728
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy improves overall survival in patients with resected gastric adenocarcinoma: A National Cancer Data Base analysis.
Stumpf PK; Amini A; Jones BL; Koshy M; Sher DJ; Lieu CH; Schefter TE; Goodman KA; Rusthoven CG
Cancer; 2017 Sep; 123(17):3402-3409. PubMed ID: 28513823
[TBL] [Abstract][Full Text] [Related]
5. No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.
Tsai C; Mueller A; Maubach J; Warschkow R; Nussbaum DP; Schmied BM; Blazer D; Gloor B; Worni M
Dig Surg; 2020; 37(3):249-257. PubMed ID: 31340206
[TBL] [Abstract][Full Text] [Related]
6. Predictors of Survival in Patients with Resectable Gastric Cancer Treated with Preoperative Chemoradiation Therapy and Gastrectomy.
Badgwell B; Blum M; Estrella J; Chiang YJ; Das P; Matamoros A; Fournier K; Mansfield P; Ajani J
J Am Coll Surg; 2015 Jul; 221(1):83-90. PubMed ID: 26002780
[TBL] [Abstract][Full Text] [Related]
7. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
8. Comparative effectiveness of treatment modalities in non-metastatic gastric adenocarcinoma: a propensity score matching analysis of the National Cancer Database.
Barzi A; Yang D; Kim AW; Shah MA; Sadeghi S
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33148789
[TBL] [Abstract][Full Text] [Related]
9. Association of Preoperative Chemosensitivity With Postoperative Survival in Patients With Resected Gastric Adenocarcinoma.
Deng L; Groman A; Jiang C; Perimbeti S; Gabriel E; Kukar M; Mukherjee S
JAMA Netw Open; 2021 Nov; 4(11):e2135340. PubMed ID: 34797369
[TBL] [Abstract][Full Text] [Related]
10. The ypT category does not impact overall survival in node negative gastric cancer.
Ikoma N; Hofstetter WL; Estrella JS; Das P; Minsky BD; Fournier KF; Mansfield PF; Ajani JA; Badgwell BD
J Surg Oncol; 2018 Jun; 117(8):1721-1728. PubMed ID: 29949666
[TBL] [Abstract][Full Text] [Related]
11. Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY; Curran WJ; El-Rayes BF; Behera M; Patel PR
Cancer; 2020 Jan; 126(1):37-45. PubMed ID: 31532544
[TBL] [Abstract][Full Text] [Related]
12. Role of Adjuvant Chemotherapy in ypT0-2N0 Patients Treated with Preoperative Chemoradiation Therapy and Radical Resection for Rectal Cancer.
Park IJ; Kim DY; Kim HC; Kim NK; Kim HR; Kang SB; Choi GS; Lee KY; Kim SH; Oh ST; Lim SB; Kim JC; Oh JH; Kim SY; Lee WY; Lee JB; Yu CS
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):540-7. PubMed ID: 26068489
[TBL] [Abstract][Full Text] [Related]
13. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.
Rutter CE; Park HS; Corso CD; Lester-Coll NH; Mancini BR; Yeboa DN; Johung KL
Cancer; 2015 Dec; 121(23):4141-9. PubMed ID: 26280559
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiation Improves Survival Compared With Chemotherapy Alone in Unresected Nonmetastatic Gastric Cancer.
Li R; Hou WH; Chao J; Woo Y; Glaser S; Amini A; Nelson RA; Chen YJ
J Natl Compr Canc Netw; 2018 Aug; 16(8):950-958. PubMed ID: 30099371
[No Abstract] [Full Text] [Related]
15. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Three-Drug Induction Chemotherapy Followed by Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma.
Mizrak Kaya D; Nogueras González GM; Harada K; Blum Murphy MA; Lee JH; Bhutani MS; Weston B; Thomas I; Rogers JE; Das P; Badgwell BD; Ajani JA
Oncology; 2020; 98(8):542-548. PubMed ID: 32434189
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database.
Ecker BL; McMillan MT; Datta J; Lee MK; Karakousis GC; Vollmer CM; Drebin JA; Fraker DL; Roses RE
Cancer; 2017 May; 123(6):967-976. PubMed ID: 28263387
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Positive Margins After Definitive Resection for Gastric Adenocarcinoma and Impact of Adjuvant Therapies.
Rhome RM; Moshier E; Sarpel U; Ohri N; Mazumdar M; Buckstein MH
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1106-1115. PubMed ID: 28721894
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and impact of adjuvant chemotherapy on the long-term survival of patients with multiple gastric cancers: a propensity score matching analysis.
Lin JX; Wang ZK; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Cancer Commun (Lond); 2019 Feb; 39(1):4. PubMed ID: 30744696
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.
Ajani JA; Winter K; Okawara GS; Donohue JH; Pisters PW; Crane CH; Greskovich JF; Anne PR; Bradley JD; Willett C; Rich TA
J Clin Oncol; 2006 Aug; 24(24):3953-8. PubMed ID: 16921048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
